Europeiska unionen -
litauiska -
EMA (European Medicines Agency)
sarclisa
sanofi winthrop industrie - isatuximab - daugybinė mieloma - antinavikiniai vaistai - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
Europeiska unionen -
litauiska -
EMA (European Medicines Agency)
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
Litauen -
litauiska -
Adama
agil® 100 ec
adama - koncentruota emulsija - propakvizafopas - herbicidai
Litauen -
litauiska -
Adama
banjo forte®
adama - koncentruota suspensija - dimetomorfas + fluazinamas - fungicidai
Litauen -
litauiska -
Adama
cleave®
adama - suspoemulsija - florasulamas + fluroksipiras - herbicidai
Litauen -
litauiska -
Adama
elegant® 2fd
adama - suspoemulsija - 2.4d dichlorfenoksi acto rūgštis + florasulamas - herbicidai
Litauen -
litauiska -
Adama
goltix® 700 sc
adama - koncentruota suspensija - metamitronas - herbicidai
Litauen -
litauiska -
Adama
goltix® queen
adama - koncentruota suspensija - kvinmerakas + metamitronas - herbicidai